News Quantified

BNGO – bionano genomics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies [Yahoo! Finance]

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Bionano Genomics (NASDAQ:BNGO) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Bionano Genomics (NASDAQ:BNGO) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.

Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result [Yahoo! Finance]

Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Lind Global Fund III LP

Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC

Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC

Form 424B5 Bionano Genomics, Inc.

Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: Lind Global Fund III LP

Top News Gainers

10/16 Top Researchers to Present Discoveries Made Possible by Bionano’s Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting 417.6%

2/28 Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5 25.0%

11/12 Takeaways from AMP 2019 in Baltimore: Users of Bionano’s Saphyr System Presented Results from Multiple Studies Demonstrating the System’s Utility for a Variety of Disease Indications 24.7%

10/21 Form S-1MEF Bionano Genomics, Inc 20.0%

11/6 Novogene Adopts Bionano’s Saphyr System Adding Saphyr’s Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services 14.6%

4/24 BioNano Genomics Inc (NASDAQ: BNGO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 12.7%

6/13 Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogene 9.1%

10/22 Form EFFECT Bionano Genomics, Inc 7.4%

3/6 Form 4 Bionano Genomics, Inc For: Mar 01 Filed by: Robinson Warren 7.0%

2/20 Form 4 Bionano Genomics, Inc For: Feb 18 Filed by: Adams Heather 6.7%

Top News Decliners

10/18 Form SC 13G/A Bionano Genomics, Inc Filed by: HIRSCHMAN ORIN -49.5%

4/1 Form S-1MEF Bionano Genomics, Inc -37.4%

3/5 Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update -32.9%

3/10 Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility -30.9%

10/17 Bionano Genomics down 23% on equity offering [Seeking Alpha] -30.7%

3/31 Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility -29.3%

3/10 Form 10-K Bionano Genomics, Inc For: Dec 31 -27.0%

9/18 Form S-1 Bionano Genomics, Inc -20.1%

10/23 Form 424B4 Bionano Genomics, Inc -14.1%

11/7 Form 8-K Bionano Genomics, Inc For: Nov 07 -13.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day